Latest Insider Transactions at Eli Lilly & CO (LLY)
This section provides a real-time view of insider transactions for Eli Lilly & CO (LLY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ELI LILLY & Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ELI LILLY & Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2024
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.39%
|
$9,348
$779.0 P/Share
|
|
Dec 16
2024
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.12%
|
$14,801
$779.0 P/Share
|
|
Dec 16
2024
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.47%
|
$9,348
$779.0 P/Share
|
|
Dec 16
2024
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.03%
|
$11,685
$779.0 P/Share
|
|
Dec 16
2024
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.63%
|
$9,348
$779.0 P/Share
|
|
Nov 18
2024
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
302
+4.61%
|
$219,554
$727.2 P/Share
|
|
Nov 18
2024
|
Jamere Jackson Director |
BUY
Grant, award, or other acquisition
|
Direct |
302
+3.19%
|
$219,554
$727.2 P/Share
|
|
Nov 18
2024
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
315
+4.79%
|
$229,005
$727.2 P/Share
|
|
Nov 18
2024
|
William G Kaelin Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
302
+1.39%
|
$219,554
$727.2 P/Share
|
|
Nov 18
2024
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
322
+0.98%
|
$234,094
$727.2 P/Share
|
|
Nov 18
2024
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
315
+5.65%
|
$229,005
$727.2 P/Share
|
|
Nov 18
2024
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
318
+0.29%
|
$231,186
$727.2 P/Share
|
|
Nov 18
2024
|
Katherine Baicker Director |
BUY
Grant, award, or other acquisition
|
Direct |
302
+1.29%
|
$219,554
$727.2 P/Share
|
|
Nov 18
2024
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
320
+0.44%
|
$232,640
$727.2 P/Share
|
|
Nov 18
2024
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
315
+7.38%
|
$229,005
$727.2 P/Share
|
|
Nov 08
2024
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
900
-14.11%
|
$722,700
$803.38 P/Share
|
|
Nov 01
2024
|
Lucas Montarce EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
467
-4.05%
|
$382,006
$818.93 P/Share
|
|
Nov 01
2024
|
Lucas Montarce EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,074
+8.51%
|
-
|
|
Nov 01
2024
|
Eric Dozier EVP, HR & Diversity |
SELL
Payment of exercise price or tax liability
|
Direct |
681
-7.81%
|
$557,058
$818.93 P/Share
|
|
Nov 01
2024
|
Eric Dozier EVP, HR & Diversity |
BUY
Exercise of conversion of derivative security
|
Direct |
1,534
+14.95%
|
-
|
|
Nov 01
2024
|
Edgardo Hernandez EVP & Pres., Mfg. Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
750
-2.39%
|
$613,500
$818.93 P/Share
|
|
Nov 01
2024
|
Edgardo Hernandez EVP & Pres., Mfg. Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,687
+5.1%
|
-
|
|
Oct 31
2024
|
Jacob Van Naarden EVP & Pres., Lilly Oncology |
SELL
Bona fide gift
|
Direct |
4,302
-26.64%
|
-
|
|
Oct 21
2024
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.41%
|
$9,966
$906.13 P/Share
|
|
Oct 21
2024
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.1%
|
$14,496
$906.13 P/Share
|
|
Oct 21
2024
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.5%
|
$9,966
$906.13 P/Share
|
|
Oct 21
2024
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.02%
|
$11,778
$906.13 P/Share
|
|
Oct 21
2024
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.71%
|
$9,966
$906.13 P/Share
|
|
Sep 16
2024
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.37%
|
$9,230
$923.54 P/Share
|
|
Sep 16
2024
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.1%
|
$14,768
$923.54 P/Share
|
|
Sep 16
2024
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.5%
|
$10,153
$923.54 P/Share
|
|
Sep 16
2024
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.71%
|
$10,153
$923.54 P/Share
|
|
Sep 16
2024
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.02%
|
$11,999
$923.54 P/Share
|
|
Sep 11
2024
|
Daniel Skovronsky EVP, CSO & Pres. LRL & LLY Imm |
SELL
Bona fide gift
|
Direct |
5,724
-4.63%
|
-
|
|
Sep 10
2024
|
Daniel Skovronsky EVP, CSO & Pres. LRL & LLY Imm |
SELL
Bona fide gift
|
Direct |
111
-0.09%
|
-
|
|
Sep 03
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
24,084
-0.01%
|
$23,289,228
$967.74 P/Share
|
|
Aug 27
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
24,552
-0.0%
|
$23,790,888
$969.44 P/Share
|
|
Aug 26
2024
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
750
-10.52%
|
$712,500
$950.0 P/Share
|
|
Aug 22
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
3,196
-0.0%
|
$3,087,336
$966.64 P/Share
|
|
Aug 20
2024
|
David A Ricks President, Chair, and CEO |
SELL
Bona fide gift
|
Direct |
13,727
-2.84%
|
-
|
|
Aug 19
2024
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.37%
|
$9,210
$921.81 P/Share
|
|
Aug 19
2024
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.1%
|
$14,736
$921.81 P/Share
|
|
Aug 19
2024
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.5%
|
$10,131
$921.81 P/Share
|
|
Aug 19
2024
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.02%
|
$11,973
$921.81 P/Share
|
|
Aug 19
2024
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.72%
|
$10,131
$921.81 P/Share
|
|
Aug 12
2024
|
Anat Hakim EVP, GC & Secretary |
SELL
Bona fide gift
|
Direct |
14,700
-48.23%
|
-
|
|
Jul 15
2024
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.37%
|
$9,500
$950.46 P/Share
|
|
Jul 15
2024
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.1%
|
$15,200
$950.46 P/Share
|
|
Jul 15
2024
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.46%
|
$9,500
$950.46 P/Share
|
|
Jul 15
2024
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.02%
|
$11,400
$950.46 P/Share
|